Cargando…

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis

Diagnosis, stratification and monitoring of disease progression in amyotrophic lateral sclerosis currently rely on clinical history and examination. The phenotypic heterogeneity of amyotrophic lateral sclerosis, including extramotor cognitive impairments is now well recognized. Candidate biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menke, Ricarda A. L., Körner, Sonja, Filippini, Nicola, Douaud, Gwenaëlle, Knight, Steven, Talbot, Kevin, Turner, Martin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132644/ https://www.ncbi.nlm.nih.gov/pubmed/24951638 http://dx.doi.org/10.1093/brain/awu162

Ejemplares similares

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis
por: Bäumer, Dirk, et al.
Publicado: (2014)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis
por: Fabes, Jeremy, et al.
Publicado: (2017)

Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk
por: Menke, Ricarda A L, et al.
Publicado: (2016)

Myelin imaging in amyotrophic and primary lateral sclerosis
por: Kolind, Shannon, et al.
Publicado: (2013)

Evolution of white matter damage in amyotrophic lateral sclerosis
por: Gabel, Matt C., et al.
Publicado: (2020)

Longitudinal grey matter and metabolic contributions to cognitive changes in amyotrophic lateral sclerosis
por: Hinault, Thomas, et al.
Publicado: (2022)

Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
por: Kollewe, Katja, et al.
Publicado: (2012)

Sweet food preference in amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2017)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
por: Menke, R.A.L., et al.
Publicado: (2017)

Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum
por: Lillo, Patricia, et al.
Publicado: (2012)

Frontostriatal grey matter atrophy in amyotrophic lateral sclerosis A visual rating study
por: Radakovic, Ratko, et al.
Publicado: (2018)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis
por: Loewe, Kristian, et al.
Publicado: (2017)

Psychiatric disorders prior to amyotrophic lateral sclerosis
por: Turner, Martin R., et al.
Publicado: (2016)

Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis
por: Buhour, M-S., et al.
Publicado: (2017)

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
por: Kollewe, Katja, et al.
Publicado: (2015)

Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis
por: Tyzack, Giulia E, et al.
Publicado: (2019)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)

Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling
por: Finegan, Eoin, et al.
Publicado: (2019)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis
por: Femiano, Cinzia, et al.
Publicado: (2018)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
por: Proudfoot, Malcolm, et al.
Publicado: (2019)

Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort
por: Körner, Sonja, et al.
Publicado: (2015)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
por: Turner, Bradley J, et al.
Publicado: (2008)

Widespread Structural and Functional Connectivity Changes in Amyotrophic Lateral Sclerosis: Insights from Advanced Neuroimaging Research
por: Trojsi, Francesca, et al.
Publicado: (2012)

Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
por: Forsberg, Karin M., et al.
Publicado: (2022)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study
por: Suzuki, Yo-ichi, et al.
Publicado: (2022)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis
por: Thompson, Alexander G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uqju19ofqateoea4mqph26otl8